Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

NCT: NCT07650032 · RECRUITING

NCT IDNCT07650032
StatusRECRUITING
Start Date2026-08-01
Completion2027-09-30
SponsorAdagio Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio Medical vCLAS Ventricular Ablation System (including VTS Catheter and Console) in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Frequently Asked Questions

What is Cryoablation for Monomorphic Ventricular Tachycardia (VTS)?

Cryoablation for Monomorphic Ventricular Tachycardia (VTS) is a clinical trial registered under NCT07650032. Current status: RECRUITING.

What is the status of NCT07650032?

The current status of NCT07650032 (Cryoablation for Monomorphic Ventricular Tachycardia (VTS)) is: RECRUITING.

When did Cryoablation for Monomorphic Ventricular Tachycardia (VTS) start?

Cryoablation for Monomorphic Ventricular Tachycardia (VTS) started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑